The aromatase inhibitor letrozole enhances the effect of doxorubicin and docetaxel in an MCF7 cell line model
<p>Introduction: Post-menopausal women with estrogen receptor (ER) positive breast cancer receive adjuvant chemotherapy and endocrine therapy sequentially since tamoxifen may antagonise the cytotoxicity of chemotherapy drugs. With increased use of aromatase inhibitors (...
Hauptverfasser: | , , , , |
---|---|
Format: | Artikel |
Sprache: | English |
Veröffentlicht: |
Pensoft Publishers
2012-12-01
|
Schriftenreihe: | BioDiscovery |
Schlagworte: | |
Online Zugang: | https://biodiscovery.pensoft.net/article/8940/download/pdf/ |